TY - JOUR T1 - SARS-CoV-2 Shedding Dynamics Across the Respiratory Tract, Sex, and Disease Severity for Adult and Pediatric COVID-19 JF - medRxiv DO - 10.1101/2021.02.17.21251926 SP - 2021.02.17.21251926 AU - Paul Z. Chen AU - Niklas Bobrovitz AU - Zahra Premji AU - Marion Koopmans AU - David N. Fisman AU - Frank X. Gu Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/19/2021.02.17.21251926.abstract N2 - Background SARS-CoV-2 shedding dynamics in the upper (URT) and lower respiratory tract (LRT) remain unclear.Objective To analyze SARS-CoV-2 shedding dynamics across COVID-19 severity, the respiratory tract, sex and age cohorts (aged 0 to 17 years, 18 to 59 years, and 60 years or older).Design Systematic review and pooled analyses.Setting MEDLINE, EMBASE, CENTRAL, Web of Science Core Collection, medRxiv and bioRxiv were searched up to 20 November 2020.Participants The systematic dataset included 1,266 adults and 136 children with COVID-19.Measurements Case characteristics (COVID-19 severity, age and sex) and quantitative respiratory viral loads (rVLs).Results In the URT, adults with severe COVID-19 had higher rVLs at 1 DFSO than adults (P = 0.005) or children (P = 0.017) with nonsevere illness. Between 1-10 DFSO, severe adults had comparable rates of SARS-CoV-2 clearance from the URT as nonsevere adults (P = 0.479) and nonsevere children (P = 0.863). In the LRT, severe adults showed higher post-symptom-onset rVLs than nonsevere adults (P = 0.006). In the analyzed period (4-10 DFSO), severely affected adults had no significant trend in SARS-CoV-2 clearance from LRT (P = 0.105), whereas nonsevere adults showed a clear trend (P < 0.001). After stratifying for disease severity, sex and age (including child vs. adult) were not predictive of the duration of respiratory shedding.Limitation Limited data on case comorbidities and few samples in some cohorts.Conclusion High, persistent LRT shedding of SARS-CoV-2 characterized severe COVID-19 in adults. After symptom onset, severe cases tended to have higher URT shedding than their nonsevere counterparts. Disease severity, rather than age or sex, predicted SARS-CoV-2 kinetics. LRT specimens should more accurately prognosticate COVID-19 severity than URT specimens.Primary Funding Source Natural Sciences and Engineering Research Council.Competing Interest StatementDr. Fisman has received honoraria related to work with Pfizer, Astra Zeneca and Seqirus on vaccines for respiratory viruses.Funding StatementThis study was supported by NSERC. Mr. Chen was supported by the NSERC Vanier Canada Graduate Scholarship (608544). Dr. Fisman was supported by the Canadian Institutes of Health Research (Canadian COVID-19 Rapid Research Fund, OV4-170360). Dr. Gu was supported by the NSERC Senior Industrial Research Chair.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStudy protocol, statistical code and data set: Available from Dr. Gu. ER -